
|Articles|June 23, 2022
How Freeze-Thaw Processes Can Be Used for the Commercialization of Cell and Gene Therapy
Author(s)Entegris
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
4
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
5
